EP2529774A1 — Resetting mechanism for a drug delivery device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-12-05 · 13y expired
What this patent protects
A resettable dose setting mechanism for a drug delivery device comprising a driver for driving a spindle of the drug delivery device is provided. Said driver comprises a first component (44; 207) and a second component (46; 212) rotationally coupled to said first component (44; 2…
USPTO Abstract
A resettable dose setting mechanism for a drug delivery device comprising a driver for driving a spindle of the drug delivery device is provided. Said driver comprises a first component (44; 207) and a second component (46; 212) rotationally coupled to said first component (44; 207). During resetting of said drug delivery device, said first component (44; 207) is rotationally decoupled from said second component (46; 212).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.